What sector does Genpact belong to?

Genpact operates in the Industrials sector, specifically the Data Processing & Outsourced Services industry, and is listed on the US markets.

What is the current share price of G?

As of the latest available quote, G traded at $35.14. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of G?

Genpact has a price-to-earnings (P/E) ratio of about 10.46. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of G?

The market capitalisation of Genpact is approximately $6.20B.

Is Genpact profitable?

For its latest reported financial year, Genpact recorded a net profit margin of about 10.88%.

Does G pay a dividend?

Genpact currently has a dividend yield of about 2.08%.

What is the return on equity (ROE) of G?

Genpact has a return on equity (ROE) of about 21.21%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of G?

Over the past 52 weeks, G has traded between a low of $26.85 and a high of $48.64.

Genpact

G US Industrials Data Processing & Outsourced Services

S&P 400

$35.14

+2.12%

Delayed · cached 15 min

Fair value analysis

Genpact

$35.14

Close used for this calculation

$62.72Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

75/100

Profitability17/25

Returns19/25

Balance Sheet16/25

Efficiency23/25

Growth17/25

Strong

Quality radar

Consensus fair value

$62.72

Below FV

▲ +78.5% against the close used

Model range $32.80 – $82.61

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$32.80Fair value$62.72Bull$82.61

FairClose

52-week traded range

52W low $27.5052W high $48.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Genpact closed at $35.14, 44.0% below the consensus fair value of $62.72 drawn from 9 valuation models.

Financial DNA score 75/100 — Strong. P/E of 11.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

$82.61

+135.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

$32.80

-6.7%

√(22.5 × EPS × BVPS)

EPS=3.13, BVPS=15.28 · outside Graham range (P/E 11.2, P/B 2.3) — asset-light, treat as a rough floor

P/E Fair Value

$62.60

+78.1%

EPS × 20x (sector P/E)

EPS=3.13, Sector P/E=20x

Peter Lynch (PEG)

$39.38

+12.1%

EPS × Growth% (PEG = 1 is fair)

EPS=3.13, g=12.6%

EV/EBITDA

$71.86

+104.5%

(EBITDA × 16.3x − Net Debt) ÷ Shares

EBITDA=820.87M

Dividend Discount (DDM)

$36.81

+4.8%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=0.68, r=10%, g=8%

Book Value (P/B)

$58.10

+65.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=15.28, ROE=21.2%, g=6%, r=10%

Reverse DCF

$35.14

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -0.7% | Historical: 12.6%

Margin of Safety

$44.50

+26.6%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=59.34, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer